The Real Lesson from the OpenAI Lawsuit Isn’t About AI. It’s About Trust.

The latest lawsuit against OpenAI should not be viewed simply as another AI legal challenge. It should be seen as a signal of how quickly healthcare navigation is changing. 

According to a recently filed lawsuit, a patient allegedly relied on ChatGPT for health guidance over an extended period while delaying professional medical care. The case highlights a reality that healthcare and life sciences can no longer ignore: patients are increasingly turning to AI not just for information, but for reassurance, interpretation, and guidance throughout their health experience.  

For healthcare organizations investing in generative engine optimization (GEO, or AI Search), chatbots, virtual assistants, and AI-powered patient support tools, the question is –are they designing them with this level of responsibility in mind? 

At Spectrum Science, we believe AI has enormous potential to simplify complex medical information and create more personalized patient experiences. However, it also brings great risk in the form of misinformation and hallucinations to an area where accuracy and empathy are absolute necessities.  

Pharma brands that provide helpful information through owned and social properties, as well as earned coverage, have the potential to appear in AI Search results. Disease state education content that is cited by PubMed articles, features quotes from KOL experts and patient organizations, and is structured to be read by LLMs will promote usage by AI companies. 

That’s where healthcare organizations need to be especially thoughtful. The goal of an AI-powered patient engagement program should not be maximizing interaction. It should be improving content that leads to positive health outcomes. 

Organizations deploying healthcare chatbots should first and foremost be led by patient need but co-design with the patient community and other key stakeholders is also a fundamental step to ensure the deliverable is genuinely useful and fit for integration into real-world healthcare and patient contexts.  

Important questions that must be asked include: 

• Does the chatbot address an evidenced patient unmet need? 

• Is it designed to integrate well with patient experience and preferences and with healthcare systems? 

• Does the system recognize potential signs of worsening symptoms? 

• Are there clear pathways to escalate patients to HCPs or support teams? 

• Are safety boundaries integrated into the experience itself rather than buried inside a disclaimer? 

• Is the technology consistently reinforcing its role as a source of education and support, not diagnosis or treatment? 

• Alongside the chatbot, how are we accounting for those with lower digital literacy levels, who are often the most in need of support? 

As adoption continues to accelerate, there are three watchouts healthcare brands should keep top of mind. 

1. Design for trust, not dependency. AI should empower patients and the general public with knowledge, based on reliable information sources, while strengthening their relationship with healthcare professionals.  
2. Build safety into the journey. Compliance language alone will not protect patient trust if the patient experience creates confusion about the role and limitations of AI.  
3. Continually measure how your content is being used by LLMs and optimize your approaches to help ensure your content is part of AI Search results. 

The next generation of patient engagement will be defined by how reliably people seeking helpful information get to a true diagnosis and effective treatment. If this is your goal, we’d love to help you get there. 

Stephen O’Farrell is Executive Director, Client Services and Joe Doyle is EVP, Director Omnichannel Strategy and Emerging Technology.